ENSG Q4 2025 Earnings Summary

Overall summary: Ensign delivered a record quarter and year with broad-based census and skilled mix gains, strong clinical outperformance, and disciplined yet active M&A. Management guided to double-digit EPS growth in 2026 and highlighted substantial organic runway, a robust acquisition pipeline, and ample capital capacity. While integration of a larger cohort of recent acquisitions and pacing of returns on higher-priced assets remain watch items, the tone and outlook are confident and growth-focused.

Growth

• Same-store occupancy reached 83.8% and transitioning occupancy 84.9% (both all-time highs).
• Same-store skilled days up 8.5% y/y; transitioning skilled days up 10%.
• Same-store Medicare revenue up 15.7% y/y; transitioning Medicare revenue up 11.3%; same-store Medicare days up 11%.
• Managed care revenue up 8.9% (same-store) and 15% (transitioning).
• Five-year (2020–2025) adjusted revenue up $2.7B (+111%, ~16% CAGR); adjusted EPS up $3.44 (~16% CAGR); adjusted net income up 121% (~17% CAGR).

Business development

• Acquired 17 new operations (12 real estate assets), adding 1,371 skilled nursing beds across 7 states (UT, TX, AZ, CO, AL, KS, WI).
• Recently acquired operations now represent 21.7% of the portfolio.
• Completed 40-bed addition at Vista Knoll (Vista, CA), already at 98.3% occupancy.
• Opened a replacement facility for Grossmont Post Acute (La Mesa, CA), adding 15 beds.
• Standard Bearer REIT added 12 new assets; portfolio now 154 owned properties (120 leased to Ensign affiliates; 35 to third parties).

Financials

• Issued 2026 EPS guidance of $7.41–$7.61; revenue guidance of $5.77B–$5.84B (midpoint EPS +14.3% vs. 2025; +36.5% vs. 2024).
• Standard Bearer generated Q4 rental revenue of $34.5M ($29.3M from Ensign affiliates) and FFO of $20.4M.
• Standard Bearer EBITDAR-to-rent coverage at 2.6x.

Capital & funding

• Maintains ample balance sheet dry powder to fund acquisitions and additional real estate.
• Willing to pay higher prices for strategic, high-quality assets with strong plants and synergies; expects returns to materialize over time.
• Partnerships with Omega Healthcare REIT and third-party operators to expand capacity and diversify tenant base.

Operations & strategy

• Decentralized, building-by-building transition model supports singles, small portfolios, and larger multi-state deals.
• Strong clinical performance: outperformed peers in annual surveys by 24% (state) and 33% (county); 19% advantage in 4–5 star buildings; quality measures 22% better nationally and 17% above state.
• Improving labor metrics: reduced turnover, stable wage growth, and lower staffing agency usage; DON turnover down 33% over recent years.
• Deep leadership pipeline with a record number of Administrators-in-Training (AITs).
• Focus on higher-acuity, specialty care to capture more Medicare and managed care mix.

Market & outlook

• Seeing early benefits from demographic tailwinds driving rising demand for post-acute services.
• Significant organic runway with occupancy in low-to-mid 80s, well below mature facility levels (mid-to-high 90s in examples).
• Active pipeline for Q1 2026 across portfolios, landlord transitions, nonprofit divestitures, and single-asset deals.

Risks & headwinds

• Higher-priced strategic acquisitions may take longer to achieve expected returns.
• Execution risk as recently acquired operations comprise 21.7% of the portfolio and require effective transitions.

Sentiment: positive